MedTrace Logo

Analgesic Benefit of Preoperative vs. Postoperative Etoricoxib in Total Knee Arthroplasty

NCT02534610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2015-08-27

No results posted yet for this study

Summary

Evaluation of the efficacy of preemptive versus postoperative administration of etoricoxib in total knee arthroplasty (TKA).

Conditions

  • Postoperative Pain

Interventions

DRUG

Etoricoxib

120 mg etoricoxib PO administered 1 h preoperative for group A; group B received 120 mg etoricoxib PO at the end of the surgery.

DRUG

Placebo

Group A received 1 sham pill PO at the end of the surgery; group B received 1 sham pill PO 1 h preoperative and group C received sham pill PO 1 h preoperative and 1 sham pill PO at the end of the surgery.

Sponsors & Collaborators

  • Foisor Orthopedics Clinical Hospital

    lead OTHER

Principal Investigators

  • Munteanu Ana-Maria, MD, PhD · Foisor Orthopedics Clinical Hospital Bucharest

  • Stoica I Cristian, MD, Prof. · Foisor Orthopedics Clinical Hospital Bucharest

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-08-31
Completion
2014-09-30

Countries

  • Romania

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02534610 on ClinicalTrials.gov